改善发育年龄妇女患的叶酸补充剂
Kimberly Anne Ndahayo1, Teresa Connolly2, Jennifer R Simpson1
1Department of Neurology, University of Colorado School of Medicine, Aurora; and.
Neurology. Clinical practice
|June 13, 2025
概括
在提供者教育和EHR干预后,患者女性的叶酸处方显著增加. 这项质量改进项目强调了改善产前护理和减少分娩并发症风险的策略.
科学领域:
- 神经学 神经学
- 产科和妇科 产科和妇科
- 公共卫生 公共卫生
背景情况:
- 患有的妇女 (WWE) 面临着与抗发作药物相关的出生并发症风险增加,包括自闭症和神经发育障碍.
- 叶酸补充可以减轻这些风险,使最佳的处方对生育年龄的WWE至关重要.
- 目前WWE的叶酸处方率低于最佳水平,需要采取质量改善措施.
研究的目的:
- 实施和评估一个质量改善 (QI) 项目,以增加18-47岁的患者 (WWE) 之间的叶酸处方率.
- 目标是将叶酸处方率从基线的18%提高到4级中心的50%.
主要方法:
- 利用电子健康记录 (EHR) 数据分析符合纳入标准的妇女.
- 雇佣了四个计划-做-研究-行动 (PDSA) 周期,包括提供者教育,EHR查工具的实施,患者教育传单和提供者数据报告.
- 干预措施从2022年7月到2023年3月进行.
主要成果:
- 在干预期间,生育年龄的WWE的叶酸处方率从基线17.37%增加到35.03%.
- 提供者教育和提高对处方习惯的认识表明,对处方率的影响最大.
- 这些干预措施成功实施,但没有对临床工作流程产生负面影响.
结论:
- 提供者教育和对临床指南的认识有效地增加了WWE的叶酸处方率.
- 这项QI项目展示了一种可复制的模型,用于改善产前护理和管理中的患者结果.
- 持续监测叶酸处方对于优化WWE护理至关重要.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
150
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
150
01:14Antiepileptic Drugs: Glutamate Antagonists
300
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
300
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
349
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
349
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
273
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
273
01:24Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K